as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹237.08
Change
-0.96 (-0.4%)
Open
₹236.0
Prev. Close
₹238.04
Day High
₹240.99
Day Low
₹234.4
Volume Analysis
Traded
363,969
Delivered
140,181
Delivery %
38.51%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (24.0%)
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹247.17 | ₹244.08 | ₹240.58 | ₹237.49 | ₹233.99 | ₹230.9 | ₹227.4 |
| Fibonacci | ₹244.08 | ₹241.56 | ₹240.01 | ₹237.49 | ₹234.97 | ₹233.42 | ₹230.9 |
| Camarilla | ₹238.89 | ₹238.29 | ₹237.68 | ₹237.49 | ₹236.48 | ₹235.87 | ₹235.27 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+58.16%
1 Week
-7.3%
1 Month
+6.6%
3 Months
-13.65%
6 Months
-8.53%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹82.02
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.39%
Net margin 14.7% × asset turnover 0.52x × equity multiplier 1.49x
Company Overview
Sector
Healthcare
Market Cap
₹11,039 Cr
P/E (TTM)
43.1
ROE
16.8%
Book Value
₹50.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Park Medi World Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Financial Strength (100/100), while Valuation (20/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (24.0%).
TopFund Score — Fundamentals Quality
63/100 — AverageData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Though the company is reporting repeated profits, it is not paying out dividend
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper advertisement with respect to unaudited financial results for the quarter and half year ended September 30, 2026
Crisil final monitoring report for September 2026 shows full IPO proceeds utilized, including Rudrapur hospital acquisition.
Investor Presentation for Q2 & H1 FY''27 Unaudited Results
Park Medi World reports H1 FY27 revenue ₹9,867 mn, announces 150-bed Zirakpur acquisition and 300-bed Kanpur O&M.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales + | 348 | 354 | 399 | 410 | 410 | 460 | 476 | 511 |
| Expenses + | 265 | 265 | 294 | 297 | 311 | 333 | 350 | 409 |
| Operating Profit | 83 | 88 | 105 | 113 | 99 | 127 | 126 | 102 |
| OPM % | 24.0% | 25.0% | 26.0% | 27.0% | 24.0% | 28.0% | 26.0% | 20.0% |
| Other Income + | 15 | 9 | 7 | 8 | 9 | 8 | 8 | 10 |
| Interest | 16 | 16 | 15 | 15 | 15 | 14 | 10 | 14 |
| Depreciation | 15 | 16 | 15 | 15 | 15 | 18 | 19 | 21 |
| Profit before tax | 67 | 66 | 82 | 91 | 78 | 103 | 105 | 76 |
| Tax % | 32.0% | 20.0% | 20.0% | 14.0% | 32.0% | 26.0% | 16.0% | 29.0% |
| Net Profit + | 46 | 52 | 66 | 79 | 53 | 77 | 89 | 54 |
| EPS in Rs | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — |
| YoY Sales growth | — | — | — | — | 18 | 30 | 19 | 25 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales + | 766 | 1,084 | 1,255 | 1,231 | 1,394 | 1,679 | 1,857 |
| Expenses + | 457 | 740 | 863 | 919 | 1,020 | 1,233 | 1,403 |
| Operating Profit | 309 | 345 | 391 | 312 | 374 | 446 | 455 |
| OPM % | 40.0% | 32.0% | 31.0% | 25.0% | 27.0% | 27.0% | 24.0% |
| Other Income + | 3 | 9 | 15 | 29 | 30 | 32 | 34 |
| Interest | 24 | 40 | 51 | 72 | 62 | 61 | 53 |
| Depreciation | 24 | 35 | 41 | 51 | 57 | 62 | 73 |
| Profit before tax | 265 | 278 | 315 | 218 | 286 | 355 | 363 |
| Tax % | 26.0% | 28.0% | 28.0% | 30.0% | 25.0% | 23.0% | — |
| Net Profit + | 187 | 199 | 228 | 152 | 215 | 274 | 273 |
| EPS in Rs | 4 | 5 | 6 | 4 | 5 | 6 | 6 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Sales growth | — | 42 | 16 | -2 | 13 | 21 | 23 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Reserves | 256 | 380 | 610 | 806 | 975 | 1,936 | 2,073 |
| Borrowings + | 292 | 517 | 576 | 687 | 682 | 364 | 552 |
| Other Liabilities + | 249 | 319 | 331 | 343 | 393 | 411 | 500 |
| Total Liabilities | 816 | 1,293 | 1,593 | 1,912 | 2,127 | 2,797 | 3,211 |
| Fixed Assets + | 365 | 458 | 536 | 837 | 890 | 1,309 | 1,607 |
| CWIP | 7 | 29 | 5 | 32 | 37 | 123 | 23 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 443 | 806 | 1,052 | 1,043 | 1,199 | 1,365 | 1,581 |
| Total Assets | 816 | 1,293 | 1,593 | 1,912 | 2,127 | 2,797 | 3,211 |
| Equity Capital | 19 | 77 | 77 | 77 | 77 | 86 | 86 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 223 | 155 | 199 | 367 | 215 | 329 |
| Cash from Investing Activity + | -233 | -248 | -234 | -76 | -100 | -316 |
| Cash from Financing Activity + | 49 | 163 | 1 | -130 | -89 | 121 |
| Net Cash Flow | 39 | 70 | -34 | 161 | 26 | 134 |
| Free Cash Flow | 86 | 64 | 106 | 299 | 70 | 209 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 96 | 72 | 76 | 150 | 80 | 96 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Public | 7.06% | 6.98% | 7.33% | 8.0% |
| Promoters | 82.89% | 82.89% | 82.89% | 82.89% |
| Government | 0.2% | 0.3% | 0.0% | 0.0% |
| FII | 1.28% | 0.86% | 0.82% | 0.88% |
| DII | 8.58% | 8.95% | 8.95% | 8.23% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Park Medi World Limited (this stock) | 11,039 | 43.1 | 5.12 | 16.8% |
| Akums Drugs And Pharma L | 11,279 | 29.9 | 3.22 | 8.45% |
| Viyash Scientific Limited | 11,285 | 46.6 | 3.56 | 7.39% |
| Metropolis Healthcare Ltd | 11,711 | 50.7 | 7.13 | 13.6% |
| Symbiotec Pharmalab Ltd | 10,354 | 70.0 | 7.6 | 11.7% |
| Yatharth Hosp & Tra C S L | 10,222 | 53.6 | 5.44 | 10.2% |
| Blue Jet Healthcare Ltd | 9,989 | 70.9 | — | 52.1% |
Which Mutual Funds Hold Park Medi World Limited?
Frequently Asked Questions about Park Medi World Limited
Park Medi World Limited (PARKHOSPS) closed at ₹237.08 on NSE on 19 November 2026, down 0.96 (0.4%) from the previous close.
Park Medi World Limited trades on the NSE (National Stock Exchange of India) under the symbol PARKHOSPS.
Park Medi World Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 43.1.
Park Medi World Limited has a dividend yield of 0.0%.
Park Medi World Limited's 52-week high is ₹305.0 and its 52-week low is ₹138.0.
Park Medi World Limited has a market capitalisation of ₹11,039 crore.
Park Medi World Limited has a TopFund Quality Score of 63/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Park Medi World Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.